Particle.news

Download on the App Store

Ozempic Sold Without Prescription as Trial Finds 3-Year Biological Age Reduction

Regulators have raised concerns over potential interactions and side effects, calling for stricter prescription controls

Image
Un nuevo estudio revela que Ozempic, medicamento usado para diabetes y pérdida de peso, podría reducir la edad biológica hasta 3.1 años en promedio/Foto: Canva
Image
Image

Overview

  • Pharmacies in La Plata have been dispensing Ozempic without the required medical prescription, despite its prescription-only status.
  • The Colegio de Farmacéuticos de la Provincia de Buenos Aires and ANMAT affirm that semaglutide treatments must be prescribed and monitored by healthcare professionals.
  • Nutritionists and physicians warn that unsupervised off-label weight-loss use can lead to gastrointestinal side effects, drug interactions and rebound weight gain.
  • In a 32-week clinical trial, weekly semaglutide injections produced an average 3.1-year reduction in biological age, accompanied by improvements in inflammation markers and organ function.
  • Varun Dwaraka, the study’s lead investigator, cautioned that prescribing Ozempic for anti-aging is premature and that further research is required.